Key result
Lipoprotein lipase shuttled into capillaries by GPIHBP1 detaches and enters the endothelial cell glycocalyx, where it mediates the margination and lipolytic processing of triglyceride-rich lipoproteins.
Why the study?
It was assumed that LPL transported into capillaries remains attached to GPIHBP1 to process TRLs, but the validity of that assumption required examination.
This study demonstrates that lipoprotein lipase detaches from GPIHBP1 to enter the endothelial glycocalyx, challenging the previous assumption that it remains bound to GPIHBP1 during intravascular triglyceride-rich lipoprotein processing.
LPL dissociation into the glycocalyx for TRL processing challenges the GPIHBP1-platform model; leaves open therapeutic implications for hypertriglyceridemia.
Lipoprotein lipase (LPL), the enzyme that carries out the lipolytic processing of triglyceride-rich lipoproteins (TRLs), is synthesized by adipocytes and myocytes and secreted into the interstitial spaces. The LPL is then bound by GPIHBP1, a GPI-anchored protein of endothelial cells (ECs), and transported across ECs to the capillary lumen. The assumption has been that the LPL that is moved into capillaries remains attached to GPIHBP1 and that GPIHBP1 serves as a platform for TRL processing. In the current studies, we examined the validity of that assumption. We found that an LPL-specific monoclonal antibody (mAb), 88B8, which lacks the ability to detect GPIHBP1-bound LPL, binds avidly to LPL within capillaries. We further demonstrated, by confocal microscopy, immunogold electron microscopy, and nanoscale secondary ion mass spectrometry analyses, that the LPL detected by mAb 88B8 is located within the EC glycocalyx, distant from the GPIHBP1 on the EC plasma membrane. The LPL within the glycocalyx mediates the margination of TRLs along capillaries and is active in TRL processing, resulting in the delivery of lipoprotein-derived lipids to immediately adjacent parenchymal cells. Thus, the LPL that GPIHBP1 transports into capillaries can detach and move into the EC glycocalyx, where it functions in the intravascular processing of TRLs.
No takes yet. Share an insight, caveat, or question.
Song et al. (2023) studied Triglyceride metabolism. Recombinant hLPL and LPL-specific monoclonal antibodies was evaluated on Localization of LPL in capillaries and its role in TRL margination. Lipoprotein lipase shuttled into capillaries by GPIHBP1 detaches and enters the endothelial cell glycocalyx, where it mediates the margination and lipolytic processing of triglyceride-rich lipoproteins.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: